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Abstract
We previously demonstrated that HIV replication is concentrated in lymph node B cell follicles 
during chronic infection and that HIV-specific CTL fail to accumulate in large numbers at those 
sites. It is unknown whether these observations can be generalized to other secondary lymphoid 
tissues, or whether virus compartmentalization occurs in the absence of CTL. We evaluated these 
questions in SIVmac239-infected rhesus macaques by quantifying SIV RNA+ cells and SIV-
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specific CTL in situ in spleen, lymph nodes and intestinal tissues obtained at several stages of 
infection. During chronic asymptomatic infection prior to simian AIDS (SAIDS), SIV-producing 
cells were more concentrated in follicular compared to extrafollicular regions of secondary 
lymphoid tissues. At day 14 of infection, when CTL have minimal impact on virus replication, 
there was no compartmentalization of SIV-producing cells. Virus compartmentalization was 
diminished in animals with SAIDS, which often have low frequency CTL responses. SIV-specific 
CTL were consistently more concentrated within extrafollicular regions of lymph node and spleen 
in chronically infected animals regardless of epitope specificity. Frequencies of SIV-specific CTL 
within follicular and extrafollicular compartments predicted SIV RNA+ cells within these 
compartments in a mixed model. Few SIV-specific CTL expressed the follicular homing molecule 
CXCR5 in the absence of the extrafollicular retention molecule CCR7, possibly accounting for the 
paucity of follicular CTL. These findings bolster the hypothesis that B cell follicles are immune 
privileged sites and suggest that strategies to augment CTL in B cell follicles could lead to 
improved viral control and possibly a functional cure for HIV infection.
Introduction
In the absence of antiretroviral therapy, HIV-1 replication continues inexorably and results 
in progressive depletion of CD4+ T cells, immunodeficiency, and ultimately death of the 
untreated host. The majority of HIV-1 replication in vivo during the chronic phase occurs in 
secondary lymphoid tissues within CD4+ T cells located in B cell follicles (1-5). SIV 
replication is also concentrated in CD4+ T cells located primarily in B cell follicles in lymph 
nodes of chronically infected rhesus macaques (6), which develop a disease similar to HIV-1 
infection in humans that progresses to simian AIDS (SAIDS) and death. Mechanisms 
underlying the compartmentalization of HIV-1 and SIV replication in B cell follicles of 
lymphoid tissues are not fully understood. Within germinal centers of B cell follicles, the 
presence of follicular dendritic cells (FDC) laden with extracellular virions (7, 8) that are 
potently infectious to CD4+ T cells (9) likely plays a significant role in HIV-1 propagation 
at those sites. Nevertheless, it is unknown why the host immune response is unable to fully 
suppress HIV-1 replication in the follicular compartment.
CD8+ cytotoxic T cells (CTL) play a key role in control of HIV-1 and SIV replication. CTL 
develop shortly after primary HIV-1 (10-12) and SIV (13, 14) infection, concurrent with 
declines in viremia. Diminished HIV-1-specific CTL responses are associated with 
progression of HIV-1 and SIV infection to AIDS (15, 16) and SAIDS (17), respectively, and 
are thought to be the result of mutations in CTL epitopes leading to immune escape (18) as 
well as loss of CD4+ T helper cells that are essential to maintenance of CTL number and 
function (19, 20). Depletion of CD8+ cells from chronically SIV-infected macaques 
increases plasma viremia by as much as 1,000-fold (21-23), further supporting the notion 
that CD8+ T cells exercise substantial antiretroviral activity in vivo. Nevertheless, efforts to 
augment virus-specific CTL through infusion of autologous ex vivo expanded virus-specific 
CTL (24-27), structured treatment interruption (28), and therapeutic vaccination (29-33) 
have failed to substantially reduce virus replication. Furthermore, HIV-1 and SIV replication 
often take place despite high frequencies of HIV-1- and SIV-specific CTL in PBMC. Thus, 
numerical deficiencies of CTL are not the fundamental cause for ongoing virus replication.
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Previously, we demonstrated that virus-specific CTL fail to accumulate in large numbers in 
B cell follicles in lymph nodes from chronically HIV-1-infected individuals without AIDS 
(1), and we hypothesized that follicles are immune privileged sites. Limited studies indicate 
that SIV replication is concentrated in B cell follicles in rhesus macaques during chronic 
disease (6), and that CTL directed at a Mamu-A1*001:01-restricted Gag epitope (Gag CM9) 
fail to accumulate in high concentrations in follicles (34). Whether CTL directed at other 
epitopes also fail to accumulate in large numbers within B cell follicles in chronic SIV 
infection is unknown. Furthermore, although some studies reported that most virus 
replication occurs in extrafollicular regions of lymphoid tissues during acute SIV infection 
(35, 36), the magnitude of virus replication in follicular and extrafollicular compartments 
has not been quantified in either early or advanced disease. More concrete information on 
the distribution of virus-producing cells in early lentivirus infection, when the nascent CTL 
response has had minimal impact on virus replication (37), or in advanced disease, when 
CTL may be dysfunctional or present at a low frequency, could provide additional insight 
into the role of CTL in the control of lentivirus replication. To address these questions, we 
investigated patterns of virus replication and distribution of virus-specific CTL that target 
multiple SIV epitopes within diverse types of secondary lymphoid tissues of SIV-infected 
rhesus macaques during acute and chronic SIV infection including some animals with 
SAIDS. We hypothesized that SIV replication is concentrated in B cell follicles within all 
secondary lymphoid tissues during chronic disease prior to SAIDS, and that virus-specific 
CTL directed at multiple SIV epitopes are primarily located in extrafollicular regions of 
secondary lymphoid tissues, resulting in high in vivo virus-specific CTL (effector) to SIV 
RNA+ (target) cell ratios (E:T) in extrafollicular compartments and low E:T in follicles. We 
further hypothesized that there is less compartmentalization of virus replication within B cell 
follicles 14 days after SIV infection, when the newly evolving virus-specific CTL response 
has had minimal impact on virus replication (37), or during SAIDS, when the CTL response 
is often attenuated (17).
Materials and Methods
Tissue Collection
Lymph nodes, spleen, and intestinal tissues including ileum, cecum, and colon, were 
obtained from SIVmac239-infected and uninfected Indian rhesus macaques. Axillary and/or 
inguinal lymph nodes were obtained from all animals. Mesenteric lymph nodes, spleen and 
intestinal tissues were only obtained from animals at necropsy, which are indicated in Table 
1 with the letter “N” appended to the identification number. Five animals (2H2, OH7, 8G5, 
r03094, and 4440) had samples collected at more than one time point. Twelve animals were 
inoculated with SIVmac239 intra-rectally, 10 intravenously and one intra-vaginally. Most 
animals were controls for vaccine studies. Three animals (r01106, RhAU10, RhAX18) were 
members of an elite controller cohort of rhesus macaques that express the Mamu-B*008:01 
allele (38, 39) and were sacrificed at a time when they were beginning to lose virologic 
control. Animals were housed and cared for in accordance with American Association for 
Accreditation of Laboratory Animal Care standards in accredited facilities, and all animal 
procedures were performed according to protocols approved by the Institutional Animal 
Care and Use Committees of the Wisconsin National Primate Research Center and the 
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University of Kansas. Portions of fresh lymphoid tissues were immediately snap frozen in 
OCT and/or formalin fixed and embedded in paraffin. In animals with MHC class I alleles 
known to restrict SIV-specific CTL, portions of fresh lymphoid tissue were also collected in 
RPMI 1640 with sodium heparin (18.7 U/ml) and shipped overnight to the University of 
Minnesota for in situ tetramer staining.
Localization of SIV RNA+ cells within lymphoid tissues
In situ hybridization for SIV RNA was performed using techniques similar to those 
previously used by us to detect HIV-1 RNA in lymph nodes from humans (2, 40, 41). This 
technique does not include a protease treatment step to expose encapsulated virion RNA, 
and as such primarily identifies cells that are actively transcribing SIV. Extracellular virions 
encapsulated in envelope glycoprotein and bound to FDC are detectable in some instances, 
but stain faintly in a dendritic conformation that is readily distinguished from the dark blue/
black focal staining seen in productively infected cells. Briefly, 6 μm sections of tissue were 
thaw mounted onto RNase free microscope slides, fixed in 3% paraformaldehyde (Sigma, 
St. Louis, MO) in diethyl pyrocarbonate (DEPC) (Sigma) treated phosphate buffered saline 
(PBS), and hybridized with digoxigenin labeled SIVmac239 antisense and sense probes 
(Lofstrand Laboratories, Gaithersburg, MD), overnight at 50°C. SIV RNA+ cells were 
visualized using nitro blue tetrazolium/5-bromo- (NBT/BCIP) (Roche, Nutley, NJ), as 
previously described (2, 40). In some instances, formalin fixed, paraffin embedded (FFPE) 
tissues were analyzed instead of or in addition to snap frozen tissues. FFPE tissues were 
mounted onto slides, baked for 1 hour at 60°C, deparaffinized with xylene and rehydrated 
through graded alcohols to DEPC H2O. FFPE tissues were pre-treated with proteinase K 
prior to hybridization. In animals for which both snap frozen and FFPE samples were 
available, similar frequencies of SIV RNA+ cells were detected in both tissues (data not 
shown). Immunohistochemical staining for B cells was performed in the same tissues using 
mouse anti-human CD20 (clone 7D1, AbD Serotec, Raleigh, NC), and detected using horse 
radish peroxidase (HRP) labeled polymer anti-mouse IgG (ImmPress®Kit, Vector 
Laboratories, Burlingame, CA) and Vector NovaRed substrate (Vector Laboratories). SIV 
RNA+ cells were counted by visual inspection and classified as either inside or outside of B 
cell follicles, identified morphologically as a cluster of CD20+ cells, as previously described 
by us in humans (1, 2). A minimum of 3 sections approximately 30 μm apart were analyzed 
for each tissue specimen from each animal. Total tissue area and area of follicles was 
determined by quantitative image analysis (Qwin Pro v3.4.0, Leica, Cambridge, UK) and 
used to calculate the frequency of SIV+ cells/mm2. A median of 159 mm2 (range 71 – 744 
mm2) was evaluated for spleen, 51 mm2 of tissue (range 13 – 442 mm2) for lymph node, 
223 mm2 (range, 43-359 mm2) for ileum, 80 mm2 (range, 33 – 212.mm2) for cecum, and 86 
mm2 (range, 11 – 164 mm2) for colon.
Quantification of activated and memory CD4+ cells in lymphoid tissues
Six micron frozen sections of lymph node, spleen and colon tissue from 6 animals were 
thaw mounted onto slides and fixed in 1% paraformaldehyde. Indirect immunofluorescent 
staining was performed using rabbit anti-human CD20 (Abcam®, Cambridge, MA), goat 
anti-CD4 (R&D Systems, Minneapolis, MN), and mouse anti-Ki67 (clone B56, BD 
Pharmingen) or mouse anti-CD95 (clone DX2, eBiosciences, San Diego, CA) diluted in Tris 
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Buffered Saline (TBS) with 1% bovine serum albumin (BSA) and incubated for 1 hour. 
After washing in TBS, secondary antibodies of AF488-labeled anti-goat, AF594-labeled 
anti-mouse, and AF647-labeled anti-rabbit were added and incubated for 30 min. Slides 
were covered with coverslips using SlowFade Gold with DAPI (Life Technologies, Grand 
Island, NY). Images of full sections were generated at 40X using an Olympus VS120 
scanner outfitted with an OrcaR2 camera (Olympus, Center Valley, PA). Numbers of CD4+ 
cells, CD4+Ki67+ or CD4+CD95+ cells within and outside of follicles and their respective 
areas were determined for each tissue type from ten 40X images (0.02 mm2 each) using 
Qwin Pro 3.4.0 (Leica Microsystems, Wetzlar, Germany).
Localization of SIV-specific CTL in lymphoid tissues
In situ tetramer staining combined with immunohistochemistry was performed as described 
previously (1, 42). Briefly, biotinylated MHC class I monomers were loaded with peptides 
(NIH Tetramer Core Facility) and converted to MHC tetramers. MHC class I monomers 
used included Mamu-A*001:01 molecules loaded with SIV Gag CM9 (CTPYDINQM) 
peptides (43), SIV Tat SL8 (STPESANL) peptides (18) or an irrelevant negative control 
peptides FV10 (FLPSDYFPSV) from the hepatitis B virus core protein; Mamu-B*008:01 
molecules loaded with Nef RL10 (RRHRILDIYL) peptides (44), Vif RL9 (RRAIRGEQL) 
peptides (44), Vif RL8 (RRDNRRGL) peptides (44), and Env KL9 (KRQQELLRL) 
peptides (44); and Mamu-A1*002:01 monomers loaded with Nef YY9 (YTSGPGIRY) 
peptides (45). Fresh lymph node and spleen tissues were embedded in low melt agarose and 
cut using a vibratome into 200 μm thick sections. Ileum was cut with a scalpel into thin 
strips. Sections were incubated free floating with MHC-tetramers at a concentration of 
0.5μg/ml overnight. Sections were then washed, fixed with 4% paraformaldehyde, boiled 3 
times in 0.01M urea to expose epitopes, and then permeabilized and blocked with PBS-H 
containing 0.3% Triton X-100 and 2% normal goat serum for 1 h. For the secondary 
incubation, sections were incubated with rabbit anti-FITC antibodies (BioDesign, Saco, ME) 
along with rat-anti-human CD3 antibodies (AbD Serotec clone CD3-12, Raleigh, NC) and 
mouse-anti-human CD20 antibodies (Novacastra clone L26, Leica Microsystems, Inc., 
Buffalo Grove, IL) or mouse anti-perforin antibodies (Novacastra) at 4°C on a rocking 
platform overnight. For the tertiary incubation, sections were washed with PBS-H and 
incubated with Cy3-conjugated goat-anti-rabbit antibodies (Jackson ImmunoResearch, West 
Grove, PA), Alexa-488 conjugated goat-anti-mouse antibodies (Molecular probes), and 
Cy5-conjugated goat-anti-rat antibodies (Jackson ImmunoResearch) or Dylight 649-
conjugated goat anti-human IgM (Jackson ImmunoResearch) in blocking solution for 1 to 3 
days. For each animal, negative control staining was done that included either the same 
MHC molecule with irrelevant peptide, a different MHC molecule with irrelevant peptide, 
or mismatched MHC molecule loaded with SIV peptide. A subset of sections was also 
stained with mouse-anti-human CD20 antibodies (Novacastra clone L26) and Dylight 649-
conjugated goat-anti-human IgM (Jackson ImmunoResearch) to confirm both antibodies 
colocalized similarly in B cell follicles. Stained sections were imaged using an Olympus 
FluoView 1000 microscope. Confocal z-series were collected from approximately 5 μm 
from surface of the tissue section to as deep as the antibody counter-staining penetrated, 
approximately 35-45 μm into the tissue. Three-dimensional montage images of multiple 800 
× 800 pixel 200X Z-scans were created using Olympus FluoView Viewer software.
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Quantification of SIV-specific CTL in situ
Follicular areas were identified morphologically as clusters of brightly stained closely 
aggregated CD20+ cells. Follicular and extrafollicular areas were delineated using Olympus 
FluoView FV1000 software. Areas that showed loosely aggregated B cells that were 
ambiguous as to whether the area was a follicle were not included. To prevent bias, the red 
tetramer channel was turned off when follicular and extrafollicular areas were delineated. 
Cell counts were done on single z-scans. While doing the cells counts, we stepped up and 
down through the z-scans to distinguish tops and bottoms of cells from non-specific 
background staining and demarcated cells using a software tool to avoid counting the same 
cell twice. Images were exported as tif files with the area delineations used for cell counting 
maintained. Image J software was then used to trace and measure the areas delineated for 
cell counts. An average of 1.4 mm2 (range 0.2 – 5.3 mm2) was evaluated for lymph node 
and 2 mm2 of tissue (range 0.6 – 4.8 mm2) for spleen.
Evaluation of CXCR5 expression by indirect immunofluorescent staining
Six micron frozen tissue sections were stained with rabbit anti-CD20 (Abcam®) and mouse 
anti-rhCXCR5 (NIH Nonhuman Primate Reagent Resource clone 710D82.1) and detected 
using AF594 anti-rabbit Ig and AF488 anti-mouse Ig (Life Technologies). Images were 
acquired using a Leica DM5000B fluorescent microscope with appropriate filters.
Quantification of perforin expressing SIV-specific CTL in situ
Perforin expression within MHC-tetramer-binding cells was determined in confocal images 
of inguinal and tracheobronchial lymph node sections stained with MHC tetramers4 (red) 
and anti-perforin antibodies (green), as well as IgM antibodies (blue) to identify B cell 
follicles using an Olympus FluoView FV1000 confocal microscope with a 20x objective and 
1 μm z-steps. For each section, we collected multiple 800 μm × 800 μm fields and stitched 
them together to create montage images using Olympus FluoView software. We used 
FluoView Viewer software to visualize and count tetramer-binding cells that were or were 
not co-stained with perforin antibodies in follicular and extrafollicular areas. For each 
sample, an average of 97 (range, 22-300) tetramer+ cells inside follicles and an average of 
168 (range, 82-384) tetramer+ cells outside follicles were counted.
Flow cytometry to detect chemokine receptor and granzyme B expression in SIV-specific 
CTL
Cryopreserved disaggregated lymphoid tissue cells were thawed, and 1-2 × 106 
disaggregated cells were resuspended in 100 μL of tetramer staining buffer (5% fetal bovine 
serum in PBS with 0.06% sodium azide) and incubated with APC-labeled Gag CM9 
tetramer (MBL International, Woburn, MA), APC-labeled Nef RL10 tetramer (NIH 
Tetramer Core Facility, Emory University, Atlanta, GA), or BV421-labelled Nef YY9 
tetramer (NIH Tetramer Core Facility) concurrently with CXCR5-PE (eBioscience clone 
MU5UBEE), CD8-eFlour605 (eBioscience clone RPA-T8), CCR7-FITC (R&D Systems 
clone 150503), CD3-APC Cy7 (BD clone SP34-2) and Aqua Live/Dead viability marker 
(Life Technologies L34957) in the dark for 40 minutes at room temperature. Cells were 
washed twice, fixed and permeabilized at 4°C for 20 minutes (BD 55028), washed again, 
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and stained with granzyme B-PE Cy5.5 (Invitrogen clone GB11) at 4°C for 30 minutes. 
After washing twice, the cells were resuspended and data were acquired on a LSRII flow 
cytometer (Becton Dickinson Immunocytometry Systems, San Jose, CA) and analyzed using 
FlowJo (Treestar, Tree Star, Ashland, OR).
Statistical Analysis
Hypothesis tests were assumed to be two-sided with a significance level of 0.05. To control 
type-I error, a Fisher’s least protected approach was used for comparisons over tissue types 
(lymph node, intestine, and spleen). Mixed effects models were used to accommodate 
repeated measures on each animal with log10 transformations to normalize outcomes prior to 
analysis. Model estimates were back-transformed for interpretation (geometric mean 
approach). Count and area data from multiple sections were summed and SIV RNA+ 
cells/mm2 calculated. Count data were analyzed using a generalized linear model for a 
negative binomial distribution that accounted for within subjects correlation and adjusted for 
loge (area). If more than one lymph node was analyzed from a specific site obtained on the 
same date, data were reported as an average of all lymph node data from that site. For 
analyses of follicular and extrafollicular concentrations of SIV RNA+ cells, results were 
excluded if the total number of SIV RNA+ cells observed was less than 5. A minimum of 3 
follicles were required to be observed when quantifying tetramer+ cells in tissues. 
Comparing frequency of tetramer+ SIV-specific CTL between extrafollicular vs. follicular 
regions, findings were collapsed by animal (all F<E) and an exact binomial test was utilized 
to calculate a maximum p-value. SAS (version 9.3, Cary NC), R version 2.13.2 and 
GraphPad Prism (6.0) software were utilized.
Results
Rhesus macaque clinical characteristics
Secondary lymphoid tissue specimens from 6 acutely SIV-infected macaques, 14 chronically 
infected macaques without SAIDS, and 9 chronically infected macaques with SAIDS were 
evaluated. Clinical and experimental characteristics of these animals are shown in Table I. 
Acutely infected macaques had lymph nodes collected 14 days after infection; they had a 
median plasma SIV RNA viral load of 8.98 log10 copies/mL and a median CD4+ T cell 
count of 1,063 cells/mm3. Chronically infected animals without SAIDS were infected for a 
median of 22 weeks; they had a median viral load of 5.81 log10 copies/mL and a median 
CD4+ T cell count of 368 cells/mm3. Seven of the 9 animals with SAIDS had a CD4+ T cell 
count less than 200 cells/mm3. The other two animals had CD4+ T cell counts above 200 
cells/mm3, but were sacrificed due to development of conditions associated with SAIDS to 
prevent suffering. Animals with SAIDS were infected a median of 26 weeks, had a median 
viral load of 6.2 log10 copies/mL, and a median CD4+ T cell count of 142 cells/mm3.
Distribution of SIV RNA+ cells in secondary lymphoid tissues during chronic 
asymptomatic SIV infection
SIV RNA+ cells were detected by in situ hybridization in all secondary lymphoid tissue 
samples from chronically infected animals without SAIDS, as shown in representative 
images in Figure 1. Tissues from uninfected animals that were stained with anti-sense 
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probes and tissues from SIV-infected animals that were stained with sense probes were 
uniformly negative (data not shown). Within the same tissue type, i.e., lymph node or 
intestine, frequencies of SIV RNA+ cells were similar (p = 0.754) (Figure 2A). Frequencies 
of SIV RNA+ cells in spleen tended to be lower than those in lymph node, although 
differences were not statistically significant. Frequencies of SIV RNA+ cells were 
approximately six- and ten-fold lower in intestinal tissues compared to spleen (p<0.0001) 
and lymph node (p<0.0001), respectively.
SIV RNA+ cells were significantly more concentrated in B cell follicles compared to 
extrafollicular regions for all tissue types (Figure 2B). This pattern was consistent among all 
animals with one exception (R02076-N). This animal (indicated in closed circles in Figure 
2B) demonstrated similar frequencies of SIV RNA+ cells in follicular and extrafollicular 
regions in axillary and mesenteric lymph nodes, but higher frequencies within follicles 
compared to extrafollicular tissues in spleen, inguinal lymph node and intestine. Of note, 
this animal had one of the lowest CD4+ T cell counts of all the chronically infected, 
asymptomatic macaques.
Follicular:extrafollicular ratio of SIV RNA+ cells was marginally higher in spleen 
(geometric mean, 7.1) compared to lymph node (geometric mean, 3.1; p=0.0005), but was 
substantially higher in intestinal tissues (geometric mean, 32.0) compared to both lymph 
node (p<0.0001) and spleen (p<0.0001) (Figure 2B). Differences between intestine and 
other tissues were largely driven by differences in frequencies of SIV RNA+ cells in 
extrafollicular regions; there were substantially fewer SIV RNA+ cells in extrafollicular 
regions of intestinal tissues (geometric mean, 0.16 cells/mm2, 95% CI 0.081, 0.32) 
compared to spleen (geometric mean 0.45 cells/mm2, 95% CI 0.21, 0.98; p<0.0019) and 
lymph nodes (geometric mean 1.3 cells/mm2, 95% CI 0.68, 2.5; p<0.0001). Frequencies of 
SIV RNA+ cells in follicles, on the other hand, were not statistically different among the 
tissue types (p=0.32) ranging from a geometric mean of 3.2 cells/mm2 (95% CI 1.5, 7.0) in 
spleen to 3.9 cells/mm2 (95% CI 2.0, 7.6) in lymph node and 5.1 cells/mm2 (95% CI 2.5, 
10.2) in intestine. Overall, only a small fraction (geometric mean, 2.8%) of the intestinal 
tissues consisted of follicles, which was significantly lower than that in spleen (28%) and 
lymph nodes (40%) (Figure 2C). The majority of SIV RNA+ cells were found within 
follicles in both spleen and lymph nodes, whereas a geometric mean of 40% of SIV RNA+ 
cells was found in follicles in intestine (Figure 2D). Interestingly, most SIV RNA+ cells 
observed in extrafollicular regions of intestinal tissues were located close to a B cell follicle 
(e.g., Figures 1E and 1F).
To evaluate whether differences in frequencies of virus-producing cells between follicular 
and extrafollicular regions or among tissues could be related to target cell availability, 
frequencies of CD4+ cells, CD95+ (memory) CD4+ cells, and Ki67+ (activated) CD4+ cells 
were determined within spleen, lymph node, and colon of six animals (Supplemental Figure 
1). Significant differences in frequencies of CD4+ cells and CD95+CD4+ cells were 
observed between follicular and extrafollicular regions of secondary lymphoid tissues, 
although the differences varied by tissue (p<0.0001); CD4+ cells and CD95+CD4+ cells 
were significantly more abundant in follicles compared to extrafollicular regions of spleen 
(F:EF 1.5 for both; p=0.01 and 0.02, respectively) and colon (3.0 and 2.8, respectively; 
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p<0.001 for both), whereas they were significantly less abundant in follicles of lymph nodes 
compared to extrafollicular tissues (F:EF 0.6 for both; p=0.01 and 0.007, respectively) 
(Supplemental Figure 1A, 1B). Ki67+CD4+ cells, on the other hand, were more abundant in 
follicular compared to extrafollicular regions of all tissues (F:EF 1.5; p<0.003), and the 
relationship did not differ across tissues (p=0.10) (Supplemental Figure 1C). Frequencies of 
SIV RNA+ cells remained consistently higher within the follicular compartment compared 
to the extrafollicular compartment in all tissues, after adjusting for CD4+ cells (F:EF 6.3, 
95% CI 3.3, 12.0; p<0.0001), memory CD4+ cells (F:EF 6.6, 95% CI, 3.5, 12.4; p<0.0001; 
Figure 2E), or Ki67+CD4+ cells (F:EF 6.2, 95% CI, 3.2, 12.1; p<0.0001). There were no 
statistically significant differences in the F:EF ratio of virus-producing cells across spleen, 
lymph node, and colon after adjusting for frequencies of CD4+ cells (p=0.78), CD95+CD4+ 
cells (p=0.67; Figure 2E), or Ki67+CD4+ cells (p=0.55).
Distribution of SIV RNA+ cells in lymph nodes of SIV-infected macaques during acute SIV 
infection and SAIDS
Frequencies of SIV RNA+ cells were significantly lower in lymph nodes from chronically 
infected animals compared to those from animals 14 days after infection and tended to be 
lower compared to those from animals with SAIDS (Figure 3A). No evidence of 
compartmentalization of SIV RNA+ cells within B cell follicles was observed in any of the 
acutely infected animals, in marked contrast to findings seen in animals with chronic 
infection (Figure 3B). In animals with SAIDS, some demonstrated a follicular concentration 
of SIV RNA+ cells in lymph nodes, whereas others did not, and overall concentrations of 
SIV RNA+ cells were not statistically different between the two compartments (Figure 3B). 
The follicular to extrafollicular ratio of SIV RNA+ cells was significantly higher in 
chronically infected animals compared to those with acute SIV infection (p=0.0004) and 
tended to be higher compared to those with SAIDS (p=0.18) (Figure 3B). The percentage of 
tissue that consisted of follicle did not differ significantly among animals by disease stage 
(Figure 3C). Percentages of SIV RNA+ cells that resided in follicles, however, were 
significantly higher in animals with chronic infection compared to those with acute infection 
(p=0.02), and tended to be higher compared to those with SAIDS (Figure 3D). When data 
from animals at all stages of disease were combined, frequencies of SIV RNA+ cells 
predicted plasma viral load (Figure 3E). In an analysis that included all animals, the log10 
follicular:extrafollicular ratio of SIV RNA+ cells in lymph nodes predicted log10 plasma 
viral load (Figure 3F). Notably, the two animals with the highest degree of 
compartmentalization, i.e., the highest log10 follicular: extrafollicular ratio in Figure 3F, 
were both chronically infected animals that expressed the Mamu-B*008:01 MHC allele.
Distribution of SIV-specific CTL in secondary lymphoid tissues during chronic SIV 
infection
CTL directed at 7 different SIV epitopes and restricted by 3 different MHC class I molecules 
were identified by in situ MHC class I tetramer binding in secondary lymphoid tissues from 
8 animals with chronic SIV infection including SAIDS (Supplemental Table I). When SIV-
specific CTL were detected at high frequencies in one tissue from an animal, they were also 
detected in other tissues examined from that animal (Supplemental Table I). Frequencies of 
SIV-specific CTL were quantified in 23 lymph nodes from 8 animals and ranged from 10 to 
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522 cells/ mm2. SIV-specific CTL were also quantified in spleens of 6 of these animals and 
ranged from 22 to 327 cells/ mm2. Frequencies of SIV-specific CTL did not differ 
significantly between lymph nodes and spleen (p=0.44).
SIV-specific CTL were generally distributed diffusely amongst other CD8+ T cells and in 
all animals were consistently more concentrated in the extrafollicular regions in both lymph 
node and spleen compared to follicular regions regardless of the MHC class I type of the 
animal or the SIV epitope presented by the tetramer (Figure 4A). The highest frequencies of 
both follicular and extrafollicular SIV-specific CTL were found in the 3 animals that 
expressed the Mamu-B*008:01 MHC allele. In all animals, there was a range of localization 
patterns of SIV-specific CTL within follicles (Figure 5A-D). In most instances, SIV-specific 
CTL were largely absent from the follicles, as illustrated in Figure 5B and 5C. When SIV-
specific CTL were found in B cell follicles, typically they were located near the edge of the 
follicles (Figure 5C), although in some instances they were located throughout the follicle 
cross-section (Figure 5D). Scanning through three dimensions within B cell follicles 
revealed that in most follicles there were large contiguous areas that were completely devoid 
of SIV-specific CTL. The frequency of virus-specific CTL in the extrafollicular region was 
predictive of the frequency in the follicular region (4B). The median ratio of extrafollicular 
to follicular SIV-specific CTL in both lymph node and spleen was 4 (Figure 4C). There was 
no obvious difference in the extrafollicular to follicular ratios of SIV-specific CTL related to 
MHC class I allele expression or the SIV epitope targeted, although the numbers of animals 
studied was too small to exclude the possibility that such a difference exists.
In intestinal tissues, in situ tetramer staining analysis was limited to the ileum from two 
chronically infected animals (Rhau10, Rhax18), and one animal with SAIDS (R01106) and 
results were not quantified due to limited numbers of follicles detected in tissue sections. 
Rhau10 demonstrated a few B*008:01/Vif RL9- and Nef RL10-specific CTL (Supplemental 
Figure 2A) that were localized exclusively in extrafollicular regions. Rhax18 demonstrated a 
few B*008:01/Nef RL10-specific CTL scattered in the extrafollicular regions, and a larger 
number around and inside the one follicle that was observed (Supplemental Figure 2B). In 
the animal with SAIDS, R01106, B*008:01/Env KL9-specific CD8+ T cells (Supplemental 
Figure 2C) were detected at higher levels than in the other two animals. In this animal, more 
abundant extrafollicular CTL were observed than in the other two animals and, similar to 
Rhax18, large concentrations of CTL were found around and inside the B cell follicles.
Effector SIV-specific CTL to SIV RNA+ target cell (E:T) ratios in secondary lymphoid 
tissues
The in vivo E:T ratios between the dominant, i.e., most abundant SIV-specific CTL and SIV 
RNA+ cells ranged from 2 to 235 (median, 36) in lymph node and 6 to 7,509 (median, 69) in 
spleen. The E:T ratio did not correlate with plasma viral load in either lymph node (r=−0.5; 
p=0.207; 95% CI −0.89, 0.31) or spleen (r=−0.371; p=0.468; 95% CI −0.91, 0.63), although 
the number of animals studied was small and this does not exclude a relationship. Notably, 
the three animals with the lowest in vivo E:T ratios had the highest viral loads (Rh2306, 
R03094, R03111). When in vivo E:T ratios were analyzed within lymphoid follicular and 
extrafollicular compartments using the dominant SIV-specific CTL, significantly higher 
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ratios were found in extrafollicular tissues of both lymph node (median, 127) and spleen 
(median, 375) compared to follicular tissues (lymph node median, 3; spleen median, 9)
(Figure 6A).
Frequencies of the dominant virus-specific CTL, without regard to compartment, were not 
predictive of plasma viral load for either lymph node (r=−0.07; 95% CI, −0.74, 0.67; 
p=0.87) or spleen (r=−0.31; 95% CI, −0.90, 0.67; p=0.544). However in a mixed model, 
combining data from both lymph node and spleen, log10 frequencies of CTL were inversely 
related to log10 frequencies of SIV RNA+ cells in the tissue. On average, for every one log 
increase in CTL there was a 0.81 log10 decrease (95% CI −1.82, 0.20)in SIV RNA+ cells 
(p=0.089). Interestingly, when frequencies of CTL in follicular and extrafollicular 
compartments were evaluated together vis-a-vis SIV RNA+ cells in those compartments, 
there was a significant inverse relationship (Figure 6B).
Expression of CXCR5 and CCR7 on virus-specific CTL
It is well established that upregulation of CXCR5 and downregulation of CCR7 are required 
to enable the follicular subset of CD4+ T cells to migrate into B cell follicles (46). Assuming 
that a similar mechanism promotes CD8+ T cell migration into B cell follicles, we 
hypothesized that absence of CXCR5 and/or presence of CCR7 on SIV-specific CTL might 
account for low frequencies of these cells in B cell follicles. We first evaluated the 
distribution of CXCR5 in lymph nodes (n=5) and spleens (n=2) from chronically SIV-
infected rhesus macaques. We found that the majority of CXCR5+ cells were localized 
within B cell follicles, as shown in representative images in Figures 7A and 7B, confirming 
that the expected localization of CXCR5-expressing cells in B cell follicles exists in SIV 
infection. We next evaluated CXCR5 and CCR7 expression on virus-specific CTL using 
cryopreserved, disaggregated cells from spleen and lymph nodes that were stained with 
antibodies and MHC class I tetramers, and analyzed by flow cytometry (Supplemental 
Figure 3). CXCR5+CCR7- SIV-specific CTL were a minority population in all animals and 
all tissues; while the CXCR5-CCR7+ and CXCR5-CCR7- CTL subsets were the most 
abundant (Figure 7C).
Expression of CTL effector molecules by virus-specific CTL
To evaluate whether CTL dysfunction might hinder clearance of SIV-producing cells within 
B cell follicles, granzyme B and perforin expression were determined on SIV-specific CTL. 
Using disaggregated cells from the same animals as those in Figure 7E, we determined 
granzyme B staining within each chemokine receptor expressing CTL subset by flow 
cytometry (Supplemental Figure 3). As shown in Figure 8A, CXCR5 expression correlated 
with the most granzyme-expressing cells, regardless of whether they expressed CCR7, 
whereas low levels of granzyme B were observed in CXCR5- subsets. Perforin expression 
was evaluated by immunofluorescent staining within virus-specific CTL identified through 
in situ tetramer staining. As shown in Figures 8B and 8C, perforin+ and perforin- SIV-
specific CTL were observed within both follicular and extrafollicular regions of tissues, 
respectively. Perforin expression was 15.9% lower within the follicular population of SIV-
specific CTL compared to CTL in the extrafollicular region (Figure 8D).
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This is the first study to quantify and compare the distribution of virus replication within 
multiple secondary lymphoid tissues during chronic SIV disease, as well as during acute 
infection and SAIDS. This is also the first study to quantify diverse virus-specific CTL 
within follicular and extrafollicular compartments of secondary lymphoid tissues during 
chronic disease. We found that virus replication was concentrated in B cell follicles in all 
secondary lymphoid tissues of chronically infected rhesus macaques prior to SAIDS even 
after adjusting for differences in frequencies of viral target cells, demonstrating that 
compartmentalization of SIV replication is a widespread phenomenon. In contrast, the 
follicular concentration of SIV replication was uniformly absent in animals at day 14 of SIV 
infection, when the nascent CTL response has had minimal impact on virus replication (13, 
14). Furthermore, compartmentalization of SIV replication was attenuated or lost in animals 
with SAIDS, when SIV-infected macaques often have substantial reductions in CTL and 
impairments in CTL function (17). SIV-specific CTL were distributed in a pattern inverse to 
that of SIV RNA+ cells, with high concentrations of virus-specific CTL in extrafollicular 
regions and low concentrations in B cell follicles during chronic disease. Effector (CTL) to 
target (SIV RNA+) cell ratios in spleen and lymph node were on average more than 40-fold 
higher in extrafollicular regions compared to B cell follicles. Frequencies of virus-specific 
CTL within follicular and extrafollicular compartments predicted frequencies of virus-
producing cells within those sites when analyzed together, providing additional evidence 
that in vivo levels of CTL are significant determinants of virus replication. Collectively, 
these data suggest that virus-specific CTL are highly efficient at suppressing lentivirus 
replication in extrafollicular tissues during chronic, asymptomatic disease because they are 
present in those tissues in large numbers, but that they are unable to suppress virus 
replication within follicles due to low frequencies at those sites. These findings further 
bolster our hypothesis that B cell follicles are immune privileged sites due to the fact that 
CTL fail to accumulate in large numbers in that compartment, thereby establishing a 
reservoir of chronic lentivirus replication (1, 2).
This study is the first to directly compare frequencies of virus-producing cells among 
secondary lymphoid tissues during chronic infection. Importantly, we quantified virus-
producing cells using a technique that readily distinguishes between virus-producing cells 
and virions bound extracellularly to FDC, because the latter would not be targeted by CTL 
as they are not productively infected (47) and consequently do not present antigen in the 
context of MHC class I molecules required for CD8+ T cell recognition. Although the 
phenotype of SIV RNA+ cells was not determined in this study, previous studies have 
demonstrated that the majority of SIV-producing cells in secondary lymphoid tissues of 
rhesus macaques are CD4+ T cells (48, 49). Overall, frequencies of SIV RNA+ cells were 6-
fold lower in intestinal tissues compared to spleen and 10-fold lower compared to lymph 
node (Figure 2A). In light of estimates that intestine contains approximately 10 times more 
tissue than spleen (50), these data suggest that intestine harbors approximately 1.7 times 
more virus-producing cells in vivo than spleen, an organ which has generally been 
considered to harbor a minor portion of replicating virus. Recent studies have challenged the 
notion that intestinal tissues harbor the majority of CD4+ T cells in vivo (50, 51), which has 
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been the primary basis for assertions that the majority of HIV-1 and SIV replication occurs 
in the gut. Furthermore, phylogenetic studies of virus in SIV-infected rhesus macaques 
indicate that gut is not the major source of plasma virus in vivo (52, 53), and one study 
suggested that lymph nodes are the major source (54). Collectively, these data suggest that 
the intestine is a minor source of plasma virus during chronic, asymptomatic disease. Further 
studies to precisely quantify the amount of virus-producing cells in secondary lymphoid 
tissues by measuring the dimensions of the tissues could be useful in establishing the true 
contribution of each tissue type to virus production during both acute and chronic infection.
Similar levels of virus replication were seen in B cell follicles in spleen, lymph nodes, and 
intestinal tissues during chronic infection, suggesting that the factors that promote SIV 
replication within follicles are consistent across these diverse tissue environments. Location 
of the virus-producing cells within B cell follicles is highly suggestive that these cells are T 
follicular helper cells, but further studies to clarify the phenotype of these virus-producing 
cells are warranted. Marked differences in virus replication were found among 
extrafollicular regions of secondary lymphoid tissues; frequencies of SIV RNA+ cells in the 
lamina propria of intestine were on average 10- to 14-fold lower than those in the 
extrafollicular regions of spleen and lymph node, respectively. These differences appeared 
to be largely explained by lower concentrations of memory CD4+ cells in lamina propria 
compared to extrafollicular regions of spleen and lymph node, as differences in virus-
producing cells in the extrafollicular compartment disappeared after adjusting for 
frequencies of memory CD4+ cells. Relatively low numbers of memory CD4+ cells in the 
lamina propria of the intestine may exist due to either intrinsic differences among the tissues 
(50, 51) or selective loss during acute SIV infection (55). Importantly, there was no evidence 
from our studies of a more robust CTL response in the lamina propria of the ileum compared 
to extrafollicular regions of lymph nodes and spleen to account for fewer virus-producing 
cells in the lamina propria of the intestine . The observation that SIV RNA+ cells in the 
lamina propria of intestinal tissues were usually located near B cell follicles raises the 
interesting possibility that virus-producing cells in the lamina propria are cells that recently 
emigrated from follicles, possibly after being infected through interactions with FDC. 
Indeed, a major difference between the intestinal tissues and the spleen and lymph node was 
the relative paucity of follicles in the intestine, which could account for the relatively lower 
level of SIV replication in the lamina propria if most virus-producing cells originate in 
follicles. It is possible that most SIV RNA+ cells originate in follicles in lymph nodes and 
spleen as well, but because of the close adjacency of follicles in those tissues a gradient in 
distribution of extrafollicular virus-producing cells vis-a-vis the follicles is less readily 
observed.
The magnitude of compartmentalization of SIV RNA+ cells in lymph nodes, as signified by 
the follicular to extrafollicular (F:EF) ratio, was strongly related to plasma viral load (Figure 
3E). This was true not only for animals with chronic infection, but also those with acute 
infection and SAIDS. Compartmentalization of virus replication within B cell follicles has 
been associated with a beneficial phenotype in rhesus macaques infected with nef-deleted 
SIVmac239. In these animals, which usually have very low viral loads and a non-progressor 
phenotype, almost all virus-producing cells are found within B-cell follicles in secondary 
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lymphoid tissues (56). Mechanisms underlying the profound compartmentalization of virus 
replication in this model are not clear, but could include enhanced CTL killing of virus-
producing cells in extrafollicular tissues due to abrogation of Nef-induced downregulation of 
MHC class I molecules (57). Intriguingly, and in contrast to the rhesus macaque model, the 
non-progressive phenotype seen in SIV-infected sooty mangabeys is not associated with 
compartmentalization of virus replication (6). Indeed, these animals, which fail to progress 
to SAIDS despite high viral loads, demonstrate neither a follicular concentration of virus 
replication nor large numbers of virions associated with FDC (6). Reasons for this distinct 
distribution of virus-producing cells in sooty mangabeys are unclear but could include lack 
of permissiveness of T follicular helper cells to SIV, failure of FDC to bind virion antibody 
complexes, or presence of high concentrations of CTL in the follicular microenvironment. 
The failure of sooty mangabeys to develop progressive disease has been attributed to lack of 
infection of central memory cells (6). It should be noted, however, that frequencies of virus-
producing cells in lymph nodes of these animals were substantially lower than those in SIV-
infected rhesus macaques (6), which could provide an alternative explanation for their 
relatively delayed disease progression. Regardless, these findings suggest that mechanisms 
that underlie non-progressive SIV disease in sooty mangabeys may be fundamentally 
different from those in rhesus macaques.
In the present study, the lack of compartmentalization of virus replication during early SIV 
infection and diminished compartmentalization during SAIDS were interpreted as evidence 
that CTL are essential to compartmentalization of virus in B cell follicles. Alternative 
explanations should nevertheless be considered. It is possible that a highly vulnerable target 
cell population in the extrafollicular region is preferentially infected and destroyed during 
acute SIV infection, resulting in compartmentalization of virus in the B cell follicles in 
chronic disease due to loss of extrafollicular target cells. Nevertheless, a follicular 
concentration of virus replication was found even after adjusting for frequencies of total 
CD4+ cells, memory CD4+ cells or Ki67+ CD4+ cells, weighing against this explanation. In 
addition, the fact that virus replication in the extrafollicular regions was elevated in some 
animals with SAIDS and associated with loss of compartmentalization (Figure 3B) further 
argues against a theory of limited target cells in extrafollicular regions. Nevertheless, a 
change in virus coreceptor usage could have increased the permissiveness of target cells in 
the extrafollicular region, causing this loss of compartmentalization in some animals with 
advanced disease. Studies of virus coreceptor tropism or deep sequencing of the virus 
envelope to evaluate for mutations in these animals could be useful in excluding this 
possibility. Furthermore, studies of the effects of CD8 depletion on chronically infected 
macaques could further address the question of whether the extrafollicular target cell 
population is depleted or if virus replication is suppressed by CTL.
The findings that virus-specific CTL failed to accumulate in large numbers in B cell follicles 
in both spleen and lymph node during chronic SIV infection confirmed our previous 
observations in humans (1) as well as one previous description of Mamu-A1*001:01/Gag-
specific CD8 T cells in 3 SIV-infected rhesus macaques (34). The novelty of the present 
study is that this pattern was evident for multiple different SIV epitopes presented by several 
different MHC class I molecules, indicating that this is a generalized phenomenon of SIV-
specific CTL and not unique to a few animals, MHC types, or epitopes. Importantly, few 
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SIV-specific CTL expressed the follicular homing molecule CXCR5 in the absence of the 
extrafollicular retention molecule CCR7, which may account for the paucity of CTL in 
follicles. It would be important to determine in future studies whether there are differences 
in the degree of follicular localization of CTL or their expression of CXCR5 and CCR7 
related to MHC restricting molecule or SIV epitope targeted, as the present study had 
insufficient numbers of animals to address these questions. B*008:01 animals in our study 
demonstrated the largest virus-specific CTL responses as well as the highest degree of 
compartmentalization of virus replication. These animals had been previously elite 
controllers, and were beginning to lose virologic control at the time that they were studied. It 
would be important in future studies to determine whether B*008:01 animals with intact 
elite control demonstrate more compartmentalization as well as higher frequencies of 
extrafollicular CTL than B*008:01 animals that do not achieve virologic control, or 
B*008:01 animals that have completely lost virologic control.
Studies to evaluate whether follicular CTL have impairments in effector function were 
equivocal. Higher percentages of granzyme B+ cells were found in CXCR5+CTL including 
the CCR7- subset, which is presumably representative of follicular CTL. On the other hand, 
in situ studies demonstrated approximately 16% fewer follicular CTL expressed perforin 
compared to extrafollicular CTL, suggesting a possible subtle impairment in effector 
function in follicular virus-specific CTL in addition to numerical impairments. Further 
studies to evaluate the ability of follicular SIV-specific CTL to suppress virus replication 
compared to extrafollicular CTL are warranted to definitively address this question, as 
phenotypic studies do not necessarily fully reflect effector function. Such studies would 
require virus-specific CTL to be sorted prior to assay, as CXCR5 is transiently upregulated 
on CTL after antigen-specific stimulation [(58) and unpublished observations], which would 
confound results if CXCR5 is also used to identify follicular CTL. Additional factors, such 
as T regulatory cells, may also be affecting virus-specific CTL proliferation and function 
within and outside of the follicles (59), and are worthy of further investigation.
The present study has provided strong circumstantial evidence that B cell follicles are 
immune privileged sites where SIV-specific CTL that target multiple different epitopes fail 
to accumulate, thereby allowing virus replication to persist during chronic asymptomatic 
disease. Additional studies demonstrating that introduction of virus-specific CTL into 
follicles suppresses lentivirus replication at those sites would be necessary to provide 
conclusive evidence that a deficiency of CTL in follicles accounts for chronic lentivirus 
replication at those sites. It is possible that delivering CTL to follicles may not be sufficient 
to suppress virus replication. For example, germinal center B cells express high levels of 
PD-L1 in HIV-1 infection (60), which is known to inhibit CTL activity (61). Whether this 
would be functionally relevant in vivo is not clear. A recent study linked the magnitude of 
the cellular immune response in lymphoid tissues with protection from pathogenic infection 
in rhesus macaques vaccinated with a live-attenuated SIV that induces CTL (62). Whether 
CTL in these protected animals entered the follicles, however, is unknown. A better 
understanding of the immunologic and virologic milieu in B cell follicles during lentivirus 
infection and in the context of vaccination is essential to the development of effective 
preventive and therapeutic strategies for HIV-1 infection.
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Figure 1. Localization of SIV RNA+ cells in secondary lymphoid tissues of chronically infected 
rhesus macaques
Representative images of in situ hybridization for SIV RNA to identify virus-producing cells 
(blue/black cells indicated by arrows) and CD20 staining (brown) to morphologically 
identify B cell follicles in spleen (A, B), axillary lymph node (C, D), ileum (E, F) and colon 
(G, H). Images B, D, F and H are high magnification (original magnification 252X) images 
from the fields shown in A, C, E and F (original magnification 63X), respectively.
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Figure 2. Distribution of SIV RNA+ cells in secondary lymphoid tissue compartments of 
chronically SIV-infected rhesus macaques
(A) Frequencies of total SIV RNA+ cells differed among secondary lymphoid tissues 
(p<0.0001). (B) Frequencies of SIV RNA+ cells in B-cell follicles (indicated by F) and 
extrafollicular regions (indicated as EF) differed among lymphoid tissues (p<0.0001). (C) 
Percentages of secondary lymphoid tissues constituted by B cell follicles differed among 
lymphoid tissues (p<0.0001). (D) Percentages of SIV RNA+ cells located in B cell follicles 
differed among lymphoid tissues (p=0.0005). (E) Frequencies of SIV RNA+ cells in B-cell 
follicles were significantly higher than those in extrafollicular regions (P<0.0001), after 
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adjusting for frequencies of CD95+CD4+ cells in each compartment (Supplemental Figure 
1C). There were no differences in the F:EF ratio among tissues (p=0.67) nor were there 
differences in levels of SIV-producing cells in these compartments among tissues (p>0.51) 
after adjusting for CD95+CD4+ cells. Data were analyzed using a model that controlled for 
multiple observations within the same animal for each type of lymphoid tissue, indicated by 
gray brackets. Dotted horizontal lines indicate the geometric mean (GM) within the model 
for each type of tissue, which is also shown in the data below each graph. LN indicates 
lymph node. Mes indicates mesenteric.
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Figure 3. Distribution and frequency of SIV RNA+ cells in lymph nodes of rhesus macaques 
during acute infection (day 14), chronic asymptomatic infection, and simian AIDS (SAIDS)
(A) Frequencies of SIV RNA+ cells in lymph nodes. (B) Frequencies of SIV RNA+ cells in 
B cell follicles (F) compared to extrafollicular regions (EF) of lymph nodes. (C) Percentage 
of tissue that consisted of follicle did not differ among animals by disease stage. (D) 
Percentages of SIV RNA+ cells within B cell follicles. (E) Frequencies of SIV RNA+ cells 
within lymph nodes predicted plasma viral load. For every 1 log10 increase in SIV RNA+ 
cells, there was a 1.40 log10 (95% CI, 0.35, 2.45) increase in plasma viral load. (F) The F:EF 
ratio of SIV RNA+ cells in lymph nodes predicted plasma viral load. On average, viral load 
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decreased by 4.0 log10 (95% CI, −5.33, −2.67) copies/mL for each 1 log10 increase in F:EF. 
This relationship did not significantly differ by disease stage (p=0.30). Furthermore, when 
the analysis was restricted to animals with chronic, asymptomatic infection, results were still 
statistically significant (p=0.0078), with viral load decreases by 3.04 log10 (95%CI −5.12, 
−0.96) copies/mL for each 1 log10 increase in F:EF. Dotted lines link data points from 
animals that were sampled in more than one disease stage. Horizontal lines indicate 
geometric mean (GM) values.
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Figure 4. Quantification of SIV-specific CTL in compartments of lymph node (LN) and spleen 
(Sp) from chronically infected rhesus macaques
(A) Frequencies of SIV-specific CTL in follicular and extrafollicular compartments 
according to animal and CTL epitope. Frequencies of virus-specific CTL were significantly 
higher (p=0.0078) in extrafollicular regions compared to follicular regions in both lymph 
node (medians, 54 cells/mm2 versus 17 cells/mm2, respectively) and spleen (medians, 128 
cells/mm2 versus 23 cells/mm2, respectively), using an exact binomial test in which results 
for each animal were collapsed. (B) Relationship between frequencies of extrafollicular and 
follicular SIV-specific CTL. Samples from spleen are indicated with a circle, whereas all 
others are from lymph node. Extrafollicular SIV-specific CTL was a significant predictor of 
follicular CTL (p=0.0024). For every 1 log10 increase in extrafollicular SIV-specific CTL, 
there was on average a 0.72 log10 (95% CI, 0.30, 1.14) increase in follicular CTL. (C) Ratio 
of extrafollicular (EF) to follicular (F) SIV-specific CTL. *indicates animals who had no 
SIV-specific CTL detected in folliclesIn these cases, a value of 1 cell per total tissue area 
evaluated was assigned. For animal R01106, the EF:F Nef RL10-specific CTL ratio was 54. 
Abbreviations: Sp=spleen; In=inguinal lymph node; Ax=axillary lymph node; Il=iliac lymph 
node; MC=mesocolonic lymph node; Ms=mesenteric lymph node.
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Figure 5. Localization of SIV-specific CTL in secondary lymphoid tissues of rhesus macaques 
during chronic infection
Representative lymph node tissue sections stained with MHC class I tetramers (red) to label 
SIV-specific CTL, CD3 antibodies (blue) to label T cells, and CD20 antibodies (green) to 
label B cells and delineate B cell follicles. (A) Shows a montage of multiple confocal 
projected z-scans from an inguinal lymph node from animal Rhau10 stained with Mamu-
B*008:01/Vif RL8 tetramers. (B-D) are confocal z-scans showing the range of localization 
patterns of SIV-specific CTL within follicles typically seen in spleen and lymph nodes from 
animals in the study. (B) Enlargement from A demonstrating a B cell follicle devoid of CTL. 
(C) Tissue section from the same lymph node shown in A and B now stained with Mamu-
B*008:01/Vif RL9 tetramers demonstrating an example of CTL located on the follicle edge. 
(D) A mesocolonic lymph node section from animal R03116 stained with Mamu-
A*001:01/Gag CM9 tetramers exemplifying CTL distributed throughout a follicle. Tetramer
+ cells within the sections were identified in montages of high-resolution serial z-scans, and 
are indicated by arrows in B-D. Within individual z-scans, tops and bottoms of cells were 
distinguished from non-specific background staining by stepping up and down through the 
adjacent z-scans. Red staining in the images without arrows was determined to be 
background staining by this technique. Confocal images were collected with a 20X objective 
and each scale bar indicates 100 μm.
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Figure 6. In vivo relationships between SIV-specific CTL and SIV RNA+ cells within 
compartments of lymph node (LN) and spleen from chronically infected rhesus macaques
(A) Effector to target cell ratios of SIV-specific CTL to SIV RNA+ cells were significantly 
higher in extrafollicular (EF) compared to follicular compartments (F) for both lymph node 
(n=8) and spleen (n=6). (B) Frequencies of SIV-specific CTL within F and EF predicted 
frequencies of SIV RNA+ cells within those compartments in a mixed model analysis that 
controlled for tissue type. For every 1 log10 increase in SIV-specific CTL, there was on 
average a −0.96 change in log10 SIV RNA+ cells (95% CI, −1.31,−0.61). Results for spleen 
are summarized by the dotted line and for lymph node by the solid line. If data were 
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available for more than one CTL epitope in an animal, only the most abundant SIV-specific 
CTL response was evaluated. If data were available for multiple lymph nodes in an animal, 
results were averaged.
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Figure 7. CXCR5 expression within lymph node and spleen of chronically SIV_infected rhesus 
macaques and on SIV-specific CTL
(A,B) Representative images of a double-stained spleen section from animal Rh2123 
demonstrating that most CXCR5+ cells shown in green (A) are localized within B cell 
follicles defined by CD20 staining and shown in red (B). (C) Percentages of subsets of SIV-
specific cells defined by CXCR5 and CCR7 expression from lymph nodes and spleens of 
SIV-infected rhesus macaques as determined by flow cytometry (see gating strategy in 
Supplemental Figure 3). Each animal is indicated by a different color. Triangles indicate 
CTL directed against SIV Gag CM9, circles indicate CTL directed against Nef YY9, and 
squares indicate CTL directed against Nef RL10. Spleen tissues are indicated by a circle 
around the symbol and symbols without a circle around them indicate lymph node cells. 
Results for spleen and lymph node were not statistically different (p=0.30). Horizontal lines 
indicate the geometric mean.
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Figure 8. CTL effector protein expression within follicular and extrafollicular SIV-specific CTL 
in spleen and lymph nodes of rhesus macaques
(A) Granzyme B expression within follicular (CXCR5+CCR7-) and extrafollicular 
(CXCR5- and/or CCR7+) subsets of SIV-specific CTL as determined by tetramer staining 
and flow cytometry (see gating strategy in Supplemental Figure 3). Each animal is indicated 
by a different color. Triangles indicate CTL directed against SIV Gag CM9, circles indicate 
CTL directed against Nef YY9, and squares indicate CTL directed against Nef RL10. Spleen 
tissues are indicated by a circle around the symbol and symbols without a circle around them 
indicate lymph node cells. Granzyme B expression was significantly higher in spleen 
(horizontal dotted lines indicates mean values) compared to lymph node (horizontal solid 
lines indicate mean values) (p<0.0001). (B, C) Representative images of in situ perforin 
staining within SIV-specific CTL located in follicular (B) and extrafollicular (C) regions of 
a lymph node from animal Rh2306 stained with Mamu-A*001:01/Gag CM9 tetramers (red), 
anti-perforin antibodies (green), and anti-IgM (blue) to define B-cell follicles 
morphologically. Confocal z-scans were collected with a 20X objective. Scale bar in B is 50 
μm and in C is10 μm. (D) Percentages of perforin+ tetramer-binding cells within and outside 
of lymph node follicles determined by in situ staining. Using a generalized linear model for 
a negative binomial distribution that accounted for within subjects correlation and adjusted 
for loge (area), the percentage of perforin+ cells within the tetramer-binding population was 
approximately 15.9% (95% CI, 8.6%, 22.6%) lower in follicles compared to extrafollicular 
regions (p<0.001).
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Acute 2H2 2 10.35 822 IV c
0H7 2 10.39 1436 IV c
8G5 2 10.52 1063 IV c
r03094 2 6.61 394 R c
4440 2 7.60 1736 IV c
28827 2 6.86 d V c
Chronic Rh2284-N 12 6.40 374 R c
Rh2306-N 12 6.15 291 R A01, A02, B01
R03116-N 23 3.78 422 R A01
R03103-N 16 5.23 317 R c
R03141-N 16 6.00 324 R c
2H2 36 8.94 1408 IV c
8G5-N 43 8.67 1221 IV c
Rh2123-N 56 5.62 d IV A01, B30
R02017-N 88 5.29 d IV c
R02076-N 16 6.76 315 IV c
R03111-N 15 6.45 362 R A02
Rhau10-N 241 4.11 569 IV B08
Rhaxl8-N 78 4.97 334 R B08
4440 20 5.43 2099 IV c
SAIDSe Rhav84 28 5.52 45 IV c
Rhav77 28 5.71 123 IV c
R03094 22 6.20 194 R A01
0H7-N 20 11.32f 950 IV c
2H2-N 44 8.08 92 IV c
R97009 26 8.57 158 R c
R98019 22 6.51 489 R c
R01106-N 81 4.73 142 R B08
Rhaj10 26 5.46 53g R c
aNumbers that are followed by the letter “N” indicate animals who were euthanized and from which lymph nodes, spleen and GALT were obtained 
at necropsy.
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bAbbreviations for route of SIV infection: IV, intravenous, R, intra-rectal, V, intravaginal.
c
In situ tetramer staining not performed on this animal on this date.
d
Test not done.
eSimian AIDS (SAIDS) was defined as an animal that had <200 CD4+ T cells/mm3 and/or a SAIDS defining illness.
fViral load was performed one week prior to this time point.
gCD4+ T cell count was performed 3 months prior to this time point.
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